1 |
Azuma, Y., Kaji, K., Katogi, R., Takeshita, S. and Kudo, A.: Tumor necrosis factor-alpha induces differentiation of and bone resorption by osteoclasts. J. Cell. Biol. 275: 4858-4864, 2000
|
2 |
Barman, S.A.: Effect of nitric oxide on mitogen-activated protein kinases in neonatal pulmonary vascular smooth muscle. Lung 183: 325-335, 2005
DOI
|
3 |
Cohen, R.I., Wilson, D. and Liu, S.F: Nitric oxide modifies the sarcoplasmic reticular calcium release channel in endotoxemia by both guanosine-3',5'(cyclic) phosphate-dependent and independent pathways. Crit. Care. Med. 34:173-181, 2006
DOI
ScienceOn
|
4 |
Gowen, M., Wood, D.D., Ihrie, E.J, McGuire, M.K.B. and Russel, R.GG: An interleukin-1 like factor stimulates bone resorption in vitro. Nature 306: 378-380, 1983
DOI
ScienceOn
|
5 |
Minkin, C.: Bone acid phosphatase: tartrate-resistant acid phosphatase as a marker of osteoclast function. Calcif. Tissue Int. 34:285-290, 1982
DOI
|
6 |
Palmer, R.M.J., Andrews, T., Foxwell, N.A. and Moncada, S.: Glucocorticoids do not affect the induction of a novel calcium dependent nitric oxide synthase in rabbit chondrocytes. Biochem. Biophys. Res. Commun. 188: 209-215,1992
DOI
ScienceOn
|
7 |
Punjabi, C.J., Laskin, D.L., Heck, D.E. and Laskin, J.D.: Production of nitric oxide by murine bone marrow cells. J. Immunol. 149: 2179-2184, 1992
|
8 |
Raisz, L.G: Hormonal regulation of bone growth and remodeling. in Cell and. Molecular Biology of Vertebrate Hard Tissue CIBA Foundation Symposium 136, pp 226-238, Wiley, New York, 1988
|
9 |
Ralston, S.H., Helfrich, M.H., Grabowski, P.S. and Benjamin, N.: A role for nitric oxide in the regulation of cytokineinduced bone resorption J. Bone Miner. Res. (Suppl 1) 8: 383(abstract), 1993
|
10 |
Stem, P.H. and Diamond, J.: Sodium nitroprusside increases cyclic GMP in fetal rat bone cells and inhibits resorption of fetal rat limb bone. Res. Commun. Chem. Pathol. Pharmacol. 75: 19-27, 1992
|
11 |
Thompson, B.M., Mundy, G.R. and Chambers, T.J.: Tumor necrosis factors and induce osteoblastic cells to stimulate osteoclastic bone resorption. J. Immunol. 138: 775-779, 1987
|
12 |
Srivastava, S., Toraldo, G, Weitzmann, M.N., Cenci, S., Ross, E.P. and Pacifici, R.: Estrogen decreases osteoclast formation by down-regulating receptor activator of NF-kappaB ligand(RANKL)-induced JNK activation. J. Biol. Chem. 276:8836-8840,2001
DOI
ScienceOn
|
13 |
Tatakis, D.N.: Interleukin-l bone metabolism: A review. J. Periodontol. 64: 416-431,1993
|
14 |
Zaidi, M., Alam, A.S., Bax, B.E., Shankar, V.S., Bax, C.M., Gill, J.S., Pazianas, M., Huang, C.L., Sahinoglu, T., Moonga, B.S., Stevens, C.R. and Blake, D.R.: Role of the endothelial cell in osteoclast control: New perspectives. Bone 14: 97102, 1993
|
15 |
Cenci, S., Weitzmann, M.N., Roggia, C., Namba, N., Novack, D., Woodring, land Pacifici, R.: Estrogen deficiency induces bone loss by enhancing T-cell production of TNFalpha. J Clin. Invest. 106: 1229-1237, 2000
DOI
ScienceOn
|
16 |
Kanematsu, M., Sato, T, Takai, H., Watanabe, K., Ikeda, K. and Yamada, Y.: Prostaglandin E2 induces expression of receptor activator of nuclear factor-kappa B ligand on pre-B cells: implicationf for accelerated osteoclastogenesis in estrogen defiency. J. Bone Miner. Res. 15: 1321-1329, 2000
DOI
ScienceOn
|
17 |
Lowenstein, C.J. and Snyder, S.H.: Nitric oxide, a novel biological messenger. Cell 70: 705-707. 1992
DOI
ScienceOn
|
18 |
Nussler, A.K, DiSilvio, M., Billiar, T.R., Hoffman, R.A, Geller D.A, Selby, R., Madrigas, J. and Simmons, R.L.: Stimulation of the nitric oxide synthase pathway in human hepatocytes by cytokines and endotoxin. J. Exp. Med. 176: 261-264,1992
DOI
ScienceOn
|
19 |
Nicholson, A.G, Haites, N.E., Mckay, N.G, Wilson, H.M., MacLeod, A.M. and Benjamin, N.: Induction of nitric oxide synthase in human mesangial cells. Biochem. Biophys. Res. Commun. 193: 1269-1274, 1993
DOI
ScienceOn
|
20 |
Ralston, S.H., Ho, L.P., Helfrich, M.H., Grabowski, P.S., Johnston, P.W. and Benjamin, N.: Nitric oxide: A cytokineinduced regulator of bone resorption J. Bone Miner. Res. 10: 1040-1049, 1995
DOI
ScienceOn
|
21 |
Collin-Osdoby, P., Rothe, L., Anderson, F., Nelson, M., Maloney, W. and Osdoby, P.: RANKL and OPG expression by human microvascular endothelial cells, regulation by inflammatory cytokines, and role in human osteoclastogenesis. J. Biol. Chem. 276: 20659-20672, 2001
DOI
ScienceOn
|
22 |
Ding, A., Nathan, C.F. and Stuehr, D.J.: Release of reactive nitrogen intermediates and reacrive oxygen intermediate from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J. Immunol. 141: 2407, 1988
|
23 |
MacIntyre, I., Zaidi, M., Towhidul, Alam, A.S.M., Datta, H.K., Moonga, B.S., Kidbury, P.S., Hecker, M. and Vane, J.M.: Osteoclast inhibition: An action of nitric oxide not mediated by cyclic GMP. Proc. Natl. Acad. Sci. USA 88: 2936-2940,1991
|
24 |
Lowik, W.G.M.C., Nibbering, P.H., Van der Ruit, M. and Papapoulos, S.E.: Inducible production of nitric oxide in osteoblast-like cells and in fetal mouse bone explants is associated with suppression of osteoclastic bone resorption. J. Clin. Invest. 93: 1465-1472, 1994
DOI
ScienceOn
|
25 |
Dewhirst, F.E., Stashenko, P. P., Mole, J.E. and Tsurumachi, T.: Purification and partial sequence of human osteoclastactivating factor: Identity with interleukin 1. J. Immunol. 135:2562-2568, 1985
|
26 |
Fan, X., Roy, E., Zhu, L., Murphy, T.C., Ackert-Bicknell, C., Hart, C.M., Rosen, C., Nanes, M.S. and Rubin, J.: Nitric oxide regulates RANKL and OPG expression in bone stromal cells, Endocrinology 145: 1-9, 2004
DOI
|
27 |
Stefanovic-Racic, M., Stadler, J. and Evans, C.H.: Nitric oxide and arthritis. Arth. Rheum. 36: 1036-1044, 1993
DOI
ScienceOn
|
28 |
Freeman, B.: Free radical chemistry of nitric oxide. Chest 105(suppl): 79s-84s, 1994
DOI
|
29 |
Mundy, G.R. and Roodman, G.D.: Osteoclast ontogeny and function, In Bone and Mineral Research, vol. 5, edited by Peck, W.A, pp 209-279, Elsevier, Amsterdam, 1987
|
30 |
Scheven, B.A.A., Visser, J.W.M. and Nijweide, P.J.: In vitro osteoclast generation from different bone marrow fractions, including a highly enriched hematopoietic stem cell population. Nature 321: 79-81, 1986
DOI
ScienceOn
|
31 |
Kwak, H.J., Song, J.S., No, Z.S., Song, J.H., Yang, S.D. and Cheon, H.G: The inhibitory effects of roflumilast on lipopolysaccharide-induced nitric oxide production in RAW 264.7 cells are mediated by heme oxygenase-1 and its product carbon monoxide. Inflamm Res. 54: 508-513, 2005
DOI
|
32 |
van't Hof, R.J. and Ralston, S.H.: Nitric oxide and bone, Immunology 103:255-261,2001
DOI
|
33 |
Hofbauer, L.C.: Osteoprotegerin ligand and osteoprotegerin: novel implications for osteoclast biology and bone metabolism. Eur. J Endocrinol. 141:195-210,1999
DOI
|
34 |
Hibbs, J.B., Traintor, R.R., Vavrin, Z. and Rachlin, E.M.: Nitric oxide: A cytotoxic activated macrophage effector molecule. Biochem. Biophys. Res. Commun. 157: 87-94, 1988
DOI
ScienceOn
|
35 |
Kobayashi, K., Takahashi, N., Jimi, E., Udagawa, N., Takami, m., Kotake, S., Nakagawa, N., Kinisaki, M., Yamaguchi, K., Shima, N., Yasuda, H., Morinaga, T., Higashino, K., Martin, T.J. and Suda, T.: Tumor necosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction. J. Exp. Med. 191:275-286, 2000
DOI
|
36 |
Rubin, J., Murphy, T.C., Zhu, L., Roy, E., Nanes, M.S. and Fan, X: Mechanical strain differentially regulates endothelial nitric-oxide synthase and receptor activator of nuclear kappa B ligand expression via ERKl/2 MAPK. J. Biol. Chem. 278: 34018?34025, 2003
DOI
ScienceOn
|
37 |
Suda, T., Takahashi, N. and Martin, T.J.: Modulation of osteoclast differentiation. Endocrine. Rev. 13: 66-80, 1992
|
38 |
Kasten, T.P., Collin-Osdoby, P., Patel, N., Osdoby, P., Siegel, N.R., Misko, TP., Currie, M.G and Nickols, GA.: Potentiation of osteoclastic bone resorbing activity by inhibition of nitric oxide synthase. Proc. Natl. Acad. Sci. USA. 91: 3569-3573,1994
|
39 |
Thomson, B.M., Saklatvala, J. and Chambers, T.J.: Osteoblasts mediate interleukin 1 stimulation of bone resorption by rat osteoclast. J. Exp. Med. 164: 104-112, 1986
DOI
|
40 |
Romas, E., Sims, N.A., Hards, D.K., Lindsay, M., Quinn, J.W., Ryan, P.E, Dunstan, C.R., Martin, T.J. and Gillespie, M.T.: Osteoprotegerin reduces osteoclast numbers and prevents bone erosion in collagen-induced arthritis. Am. J. Pathol. 161 :1419-1427, 2002
DOI
ScienceOn
|
41 |
Howard, G,A.: Basic and clinical research, in Normal and abnormal bone growth, edited by Dixon, A.D. and Sarnat, B.G, pp 67-76, New York, Alan RLiss, 1985
|
42 |
Anderson, D.M., Maraskovsky, E., Billingsley, W.L.: Dougall, W.C., Tometsko, M.E., Roux, E.R., Teepe, M.C., DuBose, R.F, Cosman, D. and Galibert, L.:A homologue of the TNF receptor and its ligand enhance T-cell growth and dendriticcell function. Nature 390: 175-179, 1997
DOI
ScienceOn
|
43 |
Bertolini, D.R., Nedwin, G.E., Bringman, T.S., Smith, D.D. and Mundy, G.R.: Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors. Nature 319: 516-518, 1986
DOI
ScienceOn
|
44 |
Collin-Osdoby, P., Nickols, G.A. and Osdoby, P.: Bone cell function, regulation, and communication: A role for nitric oxide. J. Cell. Biochem. 57: 399-408, 1995
DOI
ScienceOn
|
45 |
McCall, T.R, Boughton-Smith, N.K., Palmer, R.M.J., Whittle, R.J.R. and Moncada, S.: Synthesis of nitric oxide from Larginine by neutrophils, Biochem. J. 261: 293-296, 1989
DOI
|
46 |
Ignarro, L.J.: Nitric oxide: A novel signal transduction mechanism for transcellular communication. Hypertension 16:477-483, 1990
DOI
|